Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by Translational Research in Oncology
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
Translational Research in Oncology
ClinicalTrials.gov Identifier:
NCT02115048
First received: April 9, 2014
Last updated: January 27, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)